74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Afya Ltd (Class A)
Suletud
SektorTarbekaubad (kaitseaktsiad)
14.64 -0.2
Ülevaade
Aktsiahinna muutus
24h
Min
14.5
Max
14.79
Sissetulek | 102M 252M |
|---|---|
Müük | 87M 936M |
P/E Sektori keskmine | 10.186 26.17 |
Dividenditootlus | 1.7 |
Kasumimarginaal | 26.913 |
EBITDA | 173M 480M |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +22.03% upside |
Dividenditootlus Sektori keskmine | 1.70% 3.42% |
|---|---|
Järgmine tulemuste avaldamine | 14. aug 2025 |
Turukapital | -424M 1.3B |
|---|---|
Eelmine avamishind | 14.84 |
Eelmine sulgemishind | 14.64 |
Uudiste sentiment
By Acuity
50%
50%
62 / 150 Pingereas Consumer defensive
Tehniline skoor
By Trading Central
Kindlus
Bullish Evidence
Afya Ltd (Class A) Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Afya Ltd (Class A) Prognoos
Hinnasiht
By TipRanks
22.12% tõus
12 kuu keskmine prognoos
Keskmine 18 USD 22.12%
Kõrge 23.5 USD
Madal 14 USD
Põhineb 5 Wall Streeti analüütiku instrumendi Afya Ltd (Class A) 12 kuu hinnasihil - viimase 3 kuu andmed.
Sentiment
By Acuity
62 / 150 Pingereas Tarbekaubad (kaitseaktsiad)
Uudiste sentiment
Neutral
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Keskmine
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Afya Ltd (Class A)
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
